Posted by JK22 > 2021-06-24 20:38 | Report Abuse

August . Top up more and prepare to pay for RI

Posted by MZM2511 > 2021-06-24 21:03 | Report Abuse

JK22 GLC company lagi.. So which GLC market now talking to China.
------------------
Ada plan lain, Pharma beli China vaccine seperti Sinovac untuk edaran kepada swasta.

Dan untuk Sinopharm, boleh lihat di bawah ini


Report 2: 21 May2021.

The government is open to any party that has the capability and clinical data of the Sinopharm Covid-19 vaccine to register it with the National Pharmaceutical Regulatory Agency (NPRA), says Khairy Jamaluddin (pic).

The National Covid-19 Immunisation Programme coordinating minister said that this DID NOT HAVE TO GO THROUGH PHARMANIAGA, the local registration product holder for the Sinovac vaccine.

He said there were several parties interested in bringing the Sinopharm vaccine from China.

“It can go through anybody else who wants to try and bring in the vaccine. It can be registered with the NPRA,” he said in a video late Thursday (May 20) to address several allegations made by Opposition leader Datuk Seri Anwar Ibrahim about the immunisation programme.

Source: https://mywinet.com/covid-19-those-who-want-to-bring-in-sinopharm-vaccine-can-register-it-with-npra-says-khairy/

Posted by MZM2511 > 2021-06-24 21:31 | Report Abuse

He pointed out that it is expected that in August, some PRIVATE COMPANIES will be approved to introduce the new crown vaccine from China. For example, Sinopharm vaccine can also be registered in Malaysia by then.

Source: https://www.orientaldaily.com.my/news/nation/2021/06/24/420158
-----------------

some PRIVATE COMPANIES (untuk beberapa jenis vaksin dari China untuk pasaran swasta, termasuk SinoVac yang telah diberi kebenaran kepada Pharma untuk diimport bagi kegunaan pasaran swasta) ---- Termasuk GLC juga ka ni?

Apa yang baik untuk Kanger ialah, Kanger telah ada tandatangani distributorship agreement dengan pihak Sinopharm (anak syarikatnya iaitu Sinopharm Group Hunan Changde....)

Posted by charlie chia > 2021-06-24 21:48 | Report Abuse

Is it rock bottom now to buy in at 6 cts
EGM on 28/6 to approve Right Issue with Warrant
1:1 on both
Right at 6 Cts n warrant to be advised on later date
Only problem is that Paid up is too big at 2.8 Billion
Any Sifu Can give further advise

Posted by hlh1962 > 2021-06-24 21:49 | Report Abuse

MZM. I really admire and appreciate you for the facts of kanger. As newbie in the share market it’s a helpful guidance for a lot of investors like me

Posted by hlh1962 > 2021-06-24 21:56 | Report Abuse

I am still topping up at 0.06 . I believe and still have hope in kanger (worth more than 0.06) . Happy trading brother

Posted by Peace99 > 2021-06-24 22:16 | Report Abuse

Charlie I'm not sifu. But just want to point out that the number of shares is relative to to he price per share. I think the key point related to your question is the amount of money your want to invest. Say you want to invest 6000 in Kanger, then at current 6sen you get 100,000 shares. If current price is 60sen, you get 10,000 shares. Haha,in a sense just have to keep track of the number of zeros. Of course, at 6sen investment amount must change at multiple of RM6, at 60sen the quantum is rm60, 10 times less "flexible" which is nothing to rich guy, but something to average guy like me, haha. Take care.... this is not a call to invest in Kanger....pls do your own assessment.

Posted by MZM2511 > 2021-06-24 22:47 | Report Abuse

KUALA LUMPUR: Pharmaniaga Bhd (Pharmaniaga) has taken up a financing facility from Standard Chartered Malaysia Bhd for the import and distribution of Sinovac Covid-19 vaccines to the public and private sectors.

https://www.nst.com.my/business/2021/06/701495/pharmaniaga-takes-financing-facility-stanchart-import-distribution-covid-19

Posted by Peace99 > 2021-06-24 23:05 | Report Abuse

MZM thanks for the honest update! Based on the recent news, I think not a wild imagination Kanger naik balik ke tingkat 10-15 :)

Posted by charlie chia > 2021-06-25 06:59 | Report Abuse

ANY shows before X for Right issue

Posted by lalazai9 > 2021-06-25 08:31 | Report Abuse

Gd news khairy approved sinopharm for private, kanger can earn alot since pay by private more expensive than government hehe, rdy rocket

Posted by 18KHarmoni > 2021-06-25 10:40 | Report Abuse

KJ approved???? Hahahaha, sapa KJ???? Approval by NPRA la ngok!!!!!!

Posted by charlie chia > 2021-06-25 14:00 | Report Abuse

Any updates and anybody enrol to attend their meeting on
Monday EGM

Posted by BilisMasin > 2021-06-25 20:18 | Report Abuse

https://rebrand.ly/KangerEGM

Register EGM
Vote against RI

Posted by MadCow75 > 2021-06-25 20:54 | Report Abuse

18k gold is no good... if buy choose at least 916 or 999... so u still believe buying 18k gold???

Posted by MadCow75 > 2021-06-25 20:55 | Report Abuse

ikan bilis create a telegram group... teach u goreng ikan bilis... later i create salted fish group... only teach how to back alive....

Posted by MadCow75 > 2021-06-25 20:57 | Report Abuse

i3 is so funny, some ppl run here run there told ppl this will up there will up... why?? wan to run his ticket?? then some say this will drop till wat wat wat very low... but wait till langpar drop also no seen... dunno wat langpar org bodo ... talk langpar, ki ho lan pu...

Posted by Bemillion > 2021-06-26 07:18 | Report Abuse

Kanger sinovac vacc where

Posted by Peace99 > 2021-06-26 17:11 | Report Abuse

Hi Bilismasin thanks for the link. Yes, hopefully more can register and contribute ideas, if time permits. But my humble opinion is just let ppl vote, for or against, based on their judgement.

Posted by MadCow75 > 2021-06-27 00:12 |

Post removed.Why?

Posted by aiman77 > 2021-06-27 05:16 | Report Abuse

Orang gila jer beli counter nie,jangan terpedaya,nampak murah tapi sampah,vaksin pun tak register dengan NPRA,ada hati nak bawak masuk,jangan terperdaya dengan cyber troper dia suruh topup lah,kalau ada right issue bertambah berat kaunter nie,baik sedekah kan jer duit tue lagi baik

Posted by MZM2511 > 2021-06-27 08:11 | Report Abuse

The Edge (26 June 2021):
(MYEG) is ready to supply an initial 10 million doses of Covid-19 vaccines as soon as the Government opens up private market vaccinations, the group said after inking a letter of intent with Anhui Zhifei Biopharmaceutical Co Ltd (Zhifei) for the vaccines.
MYEG said the letter of intent was signed pursuant to its receipt of a letter of no objection from the government for the group to purchase Zhifei’s vaccine.

www.bursamalaysia.com (23 November 2020):
"The Board of Directors of Kanger is pleased to announce that National Institutes of Biotechnology Malaysia (“NIBM”), an agency under the Ministry of Science, Technology and Innovation Malaysia has issued a letter which states that NIBM has no objections for Kanger to communicate with the relevant stakeholders at Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia."

NOTE:

1. The Zhifei Longcom, China Covid-19 vaccine is still in their preliminary stage of approval process with WHO. I think only the vaccines with the WHO approval will be given approval by NPRA to be imported to Malaysia. Instead, the Sinopharm Covid-19 vaccine already approved by WHO.

2. Kanger’s proposal to purchase Covid-19 vaccines for private use in Malaysia already given the the letter of no objection from NIBM, an agency under MOSTI much earlier in November 2020.

Posted by 18KHarmoni > 2021-06-27 12:24 | Report Abuse

@aiman77, tahniah!! U antara orang yang sedar tentang kanger, terus kan bagi kesedaran pada budak2 melayu yang baru2 nk beli saham, jangan terpengaruh dengan cerita2 dongeng pelobi kaunter ni

Posted by MZM2511 > 2021-06-27 12:44 | Report Abuse

@18KHaroni dan @aiman77.
Pada pandangan saya, orang gi la sahaja yang sanggup jadi naysayer dan hater untuk menjatuhkan sendiri harga saham yang mereka masih terlekat kepentingan di dalamnya.

Posted by charlie chia > 2021-06-27 14:10 | Report Abuse

Hope they can secure the sinopharm approved soon
Then will be a different scenarios
Anybody attending the virtual EGM tomorrow
I am see somebody had raised up this hot topic

Posted by 18KHarmoni > 2021-06-27 15:23 |

Post removed.Why?

Posted by MZM2511 > 2021-06-27 16:58 | Report Abuse

@18Kharmoni.
Apa awak ingat nanti Sinopharm vaksin kalau diluluskan, ia untuk Sabah saja ke?
Nanti kalau macam tu, Orang Sabah saje yang akan gunakan vaksin Sinopharm.

AWAK JUGA KENA INGAT, KHAIRY JANGKA PADA BULAN AUGUST NANTI, KADAR VAKSINASI NEGARA BARU SAJA MENCAPAI 40 %.

Kanger masih ada ruang luas untuk berniaga, kalau betul-betul dapat peluang vaksin Sinopharm tu...

Posted by MZM2511 > 2021-06-27 17:28 | Report Abuse

@18Kharmoni.

aiman77 Orang gila jer beli counter nie
-------------------
Memang aiman77 telah mengesahkan semuanya... Anda boleh duduk diam saja..
BUKAN DUDUK DIAMLAH, TAPI BAGI TAHNIAH LAGI KAT DIA. He He.
Mana telor dan maruah awak?

Posted by charlie chia > 2021-06-27 18:30 | Report Abuse

Still hv hope then to push up the share price

Posted by aiman77 > 2021-06-27 19:11 | Report Abuse

kawan2 nak beli saham baca anual report companyjangan dengar news kebanyakan menipu jer.kita bagi duit kat company untuk buat duit bukan untuk rugi..baik guna duit tue beli durian untuk family

Posted by MZM2511 > 2021-06-27 19:32 | Report Abuse

@aiman77. Mudah saja aiman77. Kawan-kawan boleh tengok sini. Adakah sebelum ini
syarikat tidak pernah membuat untung????

https://klse.i3investor.com/servlets/stk/fin/0170.jsp

Pelabur atau bakal pelabur yang bijak akan cari lebih maklumat. Kenapa dan mengapa?

Pencapaian syarikat bukannya statik.
Dalam keadaan sebelum ini sehingga sekarang berlaku pandemik Covid-19,
syarikat yang sebelum ini kukuhpun akan terjejas, terutama jika perniagaannya
banyak dipengaruhi oleh kesan pandemik.

Lihat juga prospek syarikat untuk diversify bagi mengatasi masalah semasa syarikat.

Posted by BilisMasin > 2021-06-27 19:46 |

Post removed.Why?

Posted by MZM2511 > 2021-06-27 19:51 | Report Abuse

@BilisMasin. Adakah kita semua yang telah beli saham Kanger atau akan beli saham kanger sebenarnya seprti dikatakan kawan kita ini?

-------------------

aiman77 Orang gila jer beli counter nie

Posted by MadCow75 > 2021-06-27 20:58 | Report Abuse

we r orang gila earth... wat wrong??? earth is too dangerous... go back to your mars.. y coz earth got place call bursa, for org gila... go back lar 18k amon... gila..

Posted by MadCow75 > 2021-06-27 20:59 | Report Abuse

uself r naysayer... get pay to write negative to bring price down... y talk 3 talk 4, talk langpar... ki ho lang kang...

Posted by MadCow75 > 2021-06-27 21:00 | Report Abuse

ikan bilis got a telegram group for kanger... dunno y... hate kanger so much but still wan create group... careful, he cheat u to run his other counter ticket...

Posted by MZM2511 > 2021-06-27 21:13 | Report Abuse

The new link to the new blog article on Kanger. I re-posted it with the new title: Kanger (0170) Has A Great Prospect To Secure Its Sinopharm Covid-19 Vaccine Distributorship In Malaysia.

https://klse.i3investor.com/blogs/mzm511/2021-06-27-story-h1567059168-Kanger_0170_Has_A_Great_Prospect_To_Secure_Its_Sinopharm_Covid_19_Vacci.jsp

Posted by hlh1962 > 2021-06-27 21:51 | Report Abuse

Will continue top up at 0.06 next week

Posted by charlie chia > 2021-06-27 22:02 | Report Abuse

Tomorrow those attending EGM
Pls share out the information discussed during meeting

Posted by pujut > 2021-06-28 01:40 | Report Abuse

Shot in the arm for firms with Covid vaccine deals
Key challenge is the procurement of the product itself, says MIDF Research head

BY AMIR IMRAN HUSAIN SAFRI
SUNBIZ@THESUNDAILY.COM
PETALING JAYA: As Malaysia’s Covid-19 vaccination programme picks up steam, companies that have ventured into the procurement and distribution of vaccines are set to benefit from such deals in the form of boosters to their income streams.

According to MIDF Research head Imran Yassin, the key challenge will be the procurement of the vaccine itself.

“However, it seems that, for now, this seems manageable. Besides, the varied sources of the vaccines will mitigate some of the concerns as we do not have to rely on one producer, which may lead to bottlenecks and delays in the delivery of vaccines,” he told SunBiz.

As Malaysia grapples with containing the Covid-19 pandemic, an accelerated vaccine rollout has been touted as a viable solution to its woes and set it on the right track towards economic reopening and recovery.

In developed economies such as the US and the UK, inoculation efforts have managed to turn around their struggles with the pandemic and brought them to the path of economic recovery.

The UK has logged an estimated 4.7 million Covid-19 cases to date, out of a population of 66.65 million. Since the rollout of vaccination, the country has eased curbs on certain sectors and sports events are allowed subject to conditions.

In recent weeks, the US has seen its 7-day average of new Covid-19 infections flatten to below 20,000 from a peak of 300,628 on Jan 8 after slightly more than half its population of 332 million have received at least one dose of vaccine.

With such empirical evidence, Imran opined that Malaysia’s economic recovery depends on the success of its vaccination programme. “Should herd immunity be achieved earlier, we believe that the country’s economic recovery will move in tandem and can also be achieved earlier,” he said.

Science, Technology, and Innovation Minister Khairy Jamaluddin, who serves as the National Covid-19 Immunisation Programme (NCIP) coordinating minister, announced on Thursday that the federal government is allowing state governments and private hospitals to purchase vaccines other than those used in the federal programme, provided they are approved by the World Health Organisation (WHO).

He said they could source vaccines from the same suppliers as the federal government, namely Sinovac and BioNtech-Pfizer, although the national vaccination programme’s orders will be fulfilled first.

Apart from Sinovac and BioNtech-Pfizer, WHO has approved AstraZaneca, Sinopharm, Serum Institute of India, Janssen and Moderna vaccines for emergency use.

In addition, to this, the NCIP has increased the number of mega vaccination centres. On June 21, the NCIP included Bukit Jalil Natinal Stadium in its list of mega vaccine centres. The stadium joins Kuala Lumpur Convention Centre, Setia City Convention Centre and three other mega vaccine centres that came online on June 7.

Imran views the efforts to ramp upvaccination in positive light and the immunisation objective is within reach. “The key now is to convince more rakyat to be inoculated, which is a shared responsibility and not just the government’s.”

Posted by pujut > 2021-06-28 01:42 | Report Abuse

COMPANIES WITH VACCINE DEAL BOOSTERS
-> UCREST BHD

Deal: Procurement of Sputnik V vaccine from two contract manufacturers in China, with capacity to produce between 312 and 960 million doses over 24 months.

Inked MoU with Russian Direct Investment Fund to manage contract manufacturers for the sovereign fund.

Status: The vaccine maker expects to receive approval from WHO within two months, and has to receive approval from Malaysia’s National Pharmaceutical Regulatory Agency (NPRA).


-> HO WAH GENTING BHD

Deal: Entered into joint venture with E-MO Biology Inc for the development of Covid-19 vaccine derived from existing oral poliovirus vaccine.

Status: To commence production, distribution upon the completion of phase IV trial and approval from the US Food and Drug Administration (US FDA).


-> PHARMANIAGA BHD

Deal: One of two companies that entered into Covid-19 vaccine supply agreements with the health ministry.

Entered into a purchase agreement with Sinovac for 14 million doses of ready-to-fill vaccine and to manufacture the doses domestically.

Received request for 7 million doses from state governments and GLCs.

Status: Expected to supply the federal government with 3.8 million Sinovac vaccine doses by end-June.

Expected to receive 10.4 million doses of Sinovac vaccine by end-August.

The group is able to produce 2 million doses a month


-> KANGER INTERNATIONAL BHD

Deal: Entered into an agreement for the dealership and distribution of Sinopharm’s Covid-19 vaccine.

Inked MoU with Sabah state government for the procurement and import of Sinopharm’s vaccine.

Status: Awaiting delivery schedule from vaccine supplier.


-> BINTAI KINDEN CORP BHD

Deal: Entered into a framework agreement for the commercialisation of Generex’s Ii-Key-SARS-CoV-2, for exclusive rights in Malaysia and several other countries in Southeast Asia. As a prerequisite it has to secure a pharmaceutical good distribution practice certification from the NPRA and register the product with the agency.

Status: The submission to NPRA is expected to be done by 2022/2023.

Generex has filed for a trademark application for the vaccine. Announced in January that it was preparing for a new drug application to US FDA.


-> DUOPHARMA BIOTECH BHD

Deal: Entered into an agreement with the Malaysian government for the supply of 6.4 million doses of Russia’s Sputnik V Covid-19 vaccine.

Status: The vaccine maker expects to receive approval from WHO within two months, and has to receive approval from NPRA.


-> SOLUTION GROIUP BHD

Deal: Entered into a registration, manufacturing and commercialisation agreement to market and distribute China’s CanSino Biologics’ Covid-19 vaccine. It will establish a fill-and-finish facility for the vaccine.

Entered into a supply agreement with the health ministry for 3.5 million doses of CanSino’s vaccine.

Status: Received conditional approval from the Drug Control Authority for the vaccine for emergency use.


-> WIDAD GROUP BHD

Deal: To distribute oral-based Covid-19 vaccine developed by US-based Vaxart Inc in Malaysia with Rinani Dynamic Sdn Bhd after obtaining licences and approval from the authorities in Malaysia.

Status: Vaxart to embark on phase II testing in mid-2021, will seek approval from NPRA upon obtaining approval from US FDA.


-> MY EG SERVICES BHD

Deal: Entered into a partnership with SinoPhil Biotech for the provision of a Covid-19 vaccination programme in the Philippines.

Inked letter of intent with Anhui Zhifei Biopharmaceutical Co Ltd for the supply of initial 10 million doses of the latter’s Covid-19 vaccine as soon as the government gives approval for private market vaccination.

Status: Awaiting approval by the Philippine Food and Drug Administration.

Subject to Zhifei’s vaccine meeting all rules, regulations and licensing requirements imposed by NPRA.


-> YONG TAI BHD

Deal: Exclusive distributor for Shenzhen Kangtai Biological Products Co Ltd’s inactivated KConvac vaccine with a period of five years (renewable) for no less than 20 million doses yearly.

Received the first batch of Covid-19 vaccine.

Status: Obtained NPRA’s approval on June 3 for the Clinical Trial Import License. To roll out Phase III clinical trials in Malaysia.

Posted by JK22 > 2021-06-28 10:51 | Report Abuse

Cheaper than RI now. Apa lagi ? But then have to hold few years

Posted by Kyle Yee > 2021-06-28 11:18 | Report Abuse

VERY DISSAPOINTED WITH THE EGM, SAYS WILL ANSWER Q&A after voting, after polling immediately close EGM?

Posted by Peace99 > 2021-06-28 11:40 | Report Abuse

May be they will answer later?

Posted by pujut > 2021-06-28 11:43 | Report Abuse

Lepas egm terus tutup ingat jawab soalan online..kalau betul hrp dia jawablah later..

Posted by 18KHarmoni > 2021-06-28 11:55 | Report Abuse

Hajajahaha, EGM pun mau lari, tiu nee hai

Posted by charlie chia > 2021-06-28 12:08 | Report Abuse

Wah trying to avoid problems issue
Not a professional business code of echic

Posted by BilisMasin > 2021-06-28 12:26 |

Post removed.Why?

Posted by JK22 > 2021-06-28 13:03 | Report Abuse

Warren Buffet cakap

"Our Favorite Holding Period Is Forever."
Buffett says if you don't feel comfortable owning a stock for 10 years, you shouldn't own it for 10 minutes.

Posted by Noobie123 > 2021-06-28 14:51 | Report Abuse

So what are the results from EGM? Passed all?